[127] K. Reiter, P. P. Aguilar, V. Wetter, P. Steppert, A. Tover, and A. Jungbauer,

“Separation of virus-like particles and extracellular vesicles by flow-through and

heparin affinity chromatography,” J. Chromatogr. A, vol. 1588, pp. 77–84, Mar.

2019, doi: 10.1016/J.CHROMA.2018.12.035

[128] O.-W. Merten, M. Hebben, and C. Bovolenta, “Production of lentiviral vectors,”

Mol. Ther. Methods Clin. Dev., vol. 3, no. September 2015, p. 16017, 2016.

[129] J. Transfiguracion, A. P. Manceur, E. Petiot, C. M. Thompson, and A. A. Kamen,

“Particle quantification of influenza viruses by high performance liquid chromato-

graphy,” Vaccine, vol. 33, no. 1, pp. 78–84, Jan. 2015, doi: 10.1016/j.vaccine.2014.

11.027

[130] D. Fontana, R. Kratje, M. Etcheverrigaray, and C. Prieto, “Immunogenic virus-like

particles continuously expressed in mammalian cells as a veterinary rabies vaccine

candidate,” Vaccine, vol. 33, no. 35, pp. 4238–4246, 2015, doi: 10.1016/j.vaccine.2

015.03.088

[131] S. Heider and C. Metzner, “Quantitative real-time single particle analysis of vir-

ions,” Virology, vol. 462–463, no. 100, pp. 199–206, Aug. 2014, doi: 10.1016/

j.virol.2014.06.005

[132] Q. Wang, B.-J. Bosch, J. M. Vlak, M. M. van Oers, P. J. Rottier, and J. W. M. van

Lent, “Budded baculovirus particle structure revisited,” J. Invertebr. Pathol.,

vol. 134, pp. 15–22, Feb. 2016, doi: 10.1016/j.jip.2015.12.001

[133] J. C. Akers, D. Gonda, R. Kim, B. S. Carter, and C. C. Chen, “Biogenesis of

extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and

apoptotic bodies,” J. Neurooncol., vol. 113, no. 1, pp. 1–11, May 2013, doi: 10.1

007/s11060-013-1084-8

[134] S. Gutiérrez-Granados, L. Cervera, F. Gòdia, J. Carrillo, and M. M. Segura,

“Development and validation of a quantitation assay for fluorescently tagged HIV-1

virus-like particles,” J Virol. Methods, vol. 193, no. 1, pp. 85–95, 2013, doi: 10.101

6/j.jviromet.2013.05.010

268

Bioprocessing of Viral Vaccines